Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amatsigroup Acquires Disposable-Lab | Contract Pharma
Breaking News

Amatsigroup Acquires Disposable-Lab

Enhances capabilities in development services for injectable drug products

Amatsigroup, a European contract development and manufacturing organization (CDMO) located in France, has acquired Disposable-Lab, a French company specialized in manufacturing sterile injectable clinical batches.

Founded in 2008 in Martillac, Disposable-Lab says it benefited from a growing market demand for single-use solutions for the aseptic production of technical and clinical batches to support the development of targeted new therapies based on biological molecules—immunotherapy in oncology, vaccines, etc.—as well as non-conventional processes—sterile powder filling, gene therapy, active vaccines and very small batch sizes.

Disposable-Lab reported €2.2 million in revenues in 2016 with 15 employees.

Amatsigroup made the move to buy Disposable-Lab to extend its aseptic manufacturing solutions under Good Manufacturing Practices (GMP) compliant environment; increase its overall manufacturing capacity for sterile clinical batches further to a recent investment on a second manufacturing line at its Idron’s facility; and expand its footprint in the supply of clinical services.

“This acquisition fits perfectly with our strategy of being recognized as a leader in the field of sterile clinical batches manufacturing, matching perfectly the pharmaceutical industry increasing needs,” said Alain Sainsot, chairman, Amatsigroup.

“We are very proud to join forces with Amatsigroup, a key player in clinical batches supply to the pharmaceutical industry. By leveraging the close fit between our businesses and the expertise of our teams, we will be able to develop the best possible manufacturing process to meet our customers’ requirements,” said Jean-Pascal Zambaux, founder, Disposable-Lab.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters